A detailed history of Column Capital Advisors, LLC transactions in Zoetis Inc. stock. As of the latest transaction made, Column Capital Advisors, LLC holds 167 shares of ZTS stock, worth $31,891. This represents 0.0% of its overall portfolio holdings.

Number of Shares
167
Previous 168 0.6%
Holding current value
$31,891
Previous $28,000 3.57%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 03, 2023

SELL
$167.14 - $192.77 $167 - $192
-1 Reduced 0.6%
167 $29,000
Q2 2023

Aug 08, 2023

SELL
$160.94 - $186.23 $804 - $931
-5 Reduced 2.89%
168 $28,000
Q3 2022

Nov 14, 2022

BUY
$148.29 - $182.55 $1,038 - $1,277
7 Added 4.22%
173 $26,000
Q2 2022

Aug 04, 2022

SELL
$155.97 - $200.09 $229,743 - $294,732
-1,473 Reduced 89.87%
166 $29,000
Q1 2022

May 03, 2022

SELL
$181.39 - $234.03 $1,632 - $2,106
-9 Reduced 0.55%
1,639 $309,000
Q4 2021

Feb 07, 2022

SELL
$193.69 - $247.03 $10,071 - $12,845
-52 Reduced 3.06%
1,648 $402,000
Q3 2021

Nov 10, 2021

SELL
$189.29 - $209.69 $7,193 - $7,968
-38 Reduced 2.19%
1,700 $330,000
Q2 2021

Aug 05, 2021

SELL
$155.9 - $187.99 $5,300 - $6,391
-34 Reduced 1.92%
1,738 $324,000
Q1 2021

May 10, 2021

SELL
$144.0 - $169.39 $132,048 - $155,330
-917 Reduced 34.1%
1,772 $279,000
Q4 2020

Feb 12, 2021

SELL
$157.07 - $174.35 $16,021 - $17,783
-102 Reduced 3.65%
2,689 $445,000
Q3 2020

Nov 12, 2020

SELL
$137.1 - $165.37 $5,346 - $6,449
-39 Reduced 1.38%
2,791 $462,000
Q2 2020

Aug 12, 2020

BUY
$111.92 - $142.53 $42,753 - $54,446
382 Added 15.6%
2,830 $387,000
Q1 2020

May 11, 2020

SELL
$92.66 - $144.94 $7,876 - $12,319
-85 Reduced 3.36%
2,448 $288,000
Q4 2019

Feb 14, 2020

BUY
$116.25 - $133.25 $294,461 - $337,522
2,533 New
2,533 $335,000

Others Institutions Holding ZTS

About Zoetis Inc.


  • Ticker ZTS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 468,139,008
  • Market Cap $89.4B
  • Description
  • Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...
More about ZTS
Track This Portfolio

Track Column Capital Advisors, LLC Portfolio

Follow Column Capital Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Column Capital Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Column Capital Advisors, LLC with notifications on news.